HGF to attend Festival of Biologics 2026

HGF is pleased to announce that Frédéric Didelon, Partner and European Patent Attorney in our Life Sciences team, will be attending the Festival of Biologics, taking place 13-15 October 2026 at Messe Basel, Switzerland.

The Festival of Biologics brings together professionals from across pharma, biotech, academia and the wider life sciences community to explore the latest developments across biologics discovery, development, clinical trials, manufacturing and commercialisation. The event is expected to welcome more than 3,000 attendees and 350 speakers across three days.

Frédéric brings more than 25 years of IP experience across the pharmaceutical industry, the European Patent Office and private practice, including 17 years at Novartis. He advises pharmaceutical and biotechnology companies on developing and aligning IP strategies with R&D priorities, portfolio development, partnering opportunities and product lifecycle management.

His practice spans biologics, gene therapies and nucleic acid-based therapeutics, with a particular focus on neuroscience and rare diseases. He has extensive experience in filing, prosecuting and managing patent portfolios throughout the drug development and product lifecycle.

If you are attending the Festival of Biologics and would like to discuss your IP strategy or learn more about how HGF can support innovation in the life sciences sector, get in touch with Frédéric to arrange a meeting in Basel.